Dave S. Atteberry
Papers
1
Total Citations
79
H-Index
1
About
Dave S. Atteberry is a leading figure in the health economics and outcomes research of radiation oncology, with a primary focus on optimizing treatment for spinal metastases. His most influential work employs rigorous matched-pair analyses to compare the clinical efficacy and cost-effectiveness of external beam radiation therapy (EBRT) versus stereotactic body radiation therapy (SBRT). In his landmark 2011 study, cited 79 times, Atteberry demonstrated that while SBRT offers superior local control, its higher upfront cost necessitates careful patient selection to ensure value in palliative care. This contribution has been pivotal in shaping evidence-based guidelines for managing metastatic spine disease, helping clinicians balance quality of life with economic sustainability. Beyond this core work, Atteberry’s research portfolio consistently bridges the gap between clinical oncology and healthcare policy, providing actionable data for decision-makers. His findings are frequently referenced in both clinical practice and cost-effectiveness literature, underscoring his role as a key translator of complex treatment outcomes into real-world value assessments.
Research Focus
Key Achievements
Top Papers
- 1